Two weeks ago, LifeSiteNews reported that 23 human rights groups, including two medical associations, demanded that the U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn exercise his authority under 21 CFR 2.5 to ban the abortion pill as an imminent danger to public health. The drug mifepristone (most commonly sold under the brand name "Mifeprex") blocks the pregnancy hormone progesterone, resulting in starvation of a developing child in the womb.
Mifepristone also poses risks to women so serious that the FDA placed the drug under REMS. The REMS for Mifeprex requires that women attend an in-person consultation at a qualified facility where the drug is dispensed by a certified provider. At this in-person visit, the woman must be given patient information materials that alert her to potential risks such as hemorrhage and infection (which are potentially life-threatening), and a missed extopic pregnancy diagnosis, which can also be fatal.
This is the drug that Planned Parenthood is trying to have approved as a home-delivery drug for abortion.